FDA Authorizes New COVID-19 Vaccine Formulas for Upcoming Season

The FDA has approved updated COVID-19 vaccines from Pfizer-BioNTech and Moderna for the 2026-2027 season. These mRNA vaccines target the JN.1-lineage XFG subvariant, aligning with current variant guidance. Doses will be immediately available nationwide for eligible individuals, including adults 65 and older and those aged 5-64 with underlying conditions, enhancing protection against circulating strains.